Vita means life. It's also our platform for sharing the stories of biotech's promise to patients and public health.
CSL consists of CSL Behring, CSL Seqirus and CSL Vifor. Learn more by visiting each section.
Biotechnology leader CSL Behring offers the broadest range of quality plasma-derived and recombinant therapies in our industry.
Derived from the expression 'securing health for all of us', CSL Seqirus is one of the world's largest influenza vaccine providers.
R&D focuses its expertise on four strategic platforms: plasma protein technology; recombinant technology; cell and gene therapy; and vaccines technology.
One of our core values at CSL is Innovation. We support collaborative innovation through the endowment of awards and grants to researchers around the world.
As part of our broader sustainability strategy to build a more sustainable future, CSL commits to reduce absolute Scope 1 and 2 greenhouse gas emissions by 42% by FY2030.
Along with our sustainability strategy, CSL’s community contribution framework helps deliver on our Values and support execution of our 2030 strategy.
At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out.
Whether you are early in your college education or recently completed your degree, it's never too soon to consider CSL for your Promising Future!
A global discussion about sustainability and the environment gets underway this week as world leaders, scientists and heads o…
“Elevate the voice of patients” is the theme of this year’s global event promoted by the World Health Organization.
The global biotech company announces 37 scholarships for U.S. employees and their dependents.
CSL Behring in Marburg, Germany, helped launch the Open Source Imaging Consortium (OSIC), an AI-assisted data base that has …
Experts at CSL describe this important safety system from a patient’s point of view.
Pulmonary fibrosis is a group of more than 200 diseases marked by scarring in the lungs. Learn more during September, which i…
A team from CSL Behring is in Milan, Italy, to meet with experts, share the latest scientific findings and walk the walk for …
An article, published in the journal Transfusion, analyzed U.S. donors’ self-reported responses about their health.
Take these 3 steps to start the school year off right for students who manage a rare or serious health condition.
Americas
Asia Pacific
Middle East
Europe
